Conference abstractPublished 24 Oct 2016
Advances in intestinal hyperpermeability and SIBO
Integrative Therapeutics, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Integrative practitioners are increasingly accustomed to diagnosing and treating small intestinal bacterial overgrowth (SIBO) and intestinal hyperpermeability as clinical entities. Both of these conditions are at the heart of many other known and named conditions. However, despite our ever-increasing understanding and appreciation, both SIBO and intestinal hyperpermeability require highly complex protocols, are often difficult to resolve, and prone to recurrence. Participants will learn to work with patients for whom the elimination diet has failed, patients who have increasingly difficult symptoms to manage, and those who cannot tolerate conventional approaches. The focus of our discussion will be on the dietary management of moderate to severe gastrointestinal and digestive impairment.
Subjects
Gastroenterology & HepatologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectGastroenterology & Hepatology
- BylineArticles whose byline prints “Corey Schuler”
